We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

34 hedge funds and large institutions have $22.6M invested in Faeth Therapeutics in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 13 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 13

0.14% less ownership

Funds ownership: 0.52% → 0.38% (-0.14%)

15% less funds holding

Funds holding: 40 → 34 (-6)

51% less capital invested

Capital invested by funds: $45.7M → $22.6M (-$23.1M)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
34
Holders Change
-6
Holders Change %
-15%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
14
Reduced
13
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.25M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$779K
3
FG
Formula Growth
Quebec, Canada
+$540K
4
State Street
State Street
Massachusetts
+$509K
5
AA
ALPS Advisors
Colorado
+$497K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$5.45M
2
Citadel Advisors
Citadel Advisors
Florida
-$5.05M
3
AWG
Alpha Wave Global
New York
-$3.1M
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$1.05M
5
PVI
Pura Vida Investments
New York
-$553K
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$45K -$158K -639 -73%
TRCT
27
Tower Research Capital (TRC)
New York
$14K +$10.4K +42 +145%
UBS Group
28
UBS Group
Switzerland
$7K -$17.3K -70 -67%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$7K -$741 -3 -8%
Legal & General Group
30
Legal & General Group
United Kingdom
$6K -$1.48K -6 -17%
AIP
31
Ameritas Investment Partners
Nebraska
$6K – – –
Citigroup
32
Citigroup
New York
$4K -$1.73K -7 -28%
BCV
33
Banque Cantonale Vaudoise
Switzerland
$3K +$3.71K +15 New
AIG
34
American International Group
New York
$42 -$2.22K -9 -4%
DM
35
Deerfield Management
New York
– -$5.45M -18,750 Closed
AWG
36
Alpha Wave Global
New York
– -$3.1M -10,683 Closed
Balyasny Asset Management
37
Balyasny Asset Management
Illinois
– -$401K -1,380 Closed
DKCM
38
Davidson Kempner Capital Management
New York
– -$376K -1,300 Closed
SAM
39
Serengeti Asset Management
New York
– -$291K -1,000 Closed
MWNA
40
Marshall Wace North America
New York
– -$265K -914 Closed
Osaic Holdings
41
Osaic Holdings
Arizona
– -$38K -131 Closed
SO
42
STRS Ohio
Ohio
– -$26K -90 Closed
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
– -$4K -14 Closed
1
2

FTH Hedge Fund Activity: Q2 2021 in Review

34 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q2 2021, worth a combined $22.6M — down 51% from $45.7M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of FTH and 3 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 14 added.

The largest buyer was Morgan Stanley, adding an estimated $1.25M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.45M sold.

  • 34 institutional investors held Faeth Therapeutics (FTH) as of Q2 2021, down from 40 in Q1 2021.
  • Funds reported $22.6M of Faeth Therapeutics stock for Q2 2021, down 51% quarter-over-quarter.
  • 3 funds opened new Faeth Therapeutics positions in Q2 2021 and 9 closed out, a net change of -6 holders.
  • The largest Faeth Therapeutics buyer in Q2 2021 was Morgan Stanley, an estimated $1.25M added.
  • The largest Faeth Therapeutics seller in Q2 2021 was Deerfield Management, an estimated $5.45M sold.

Based on aggregated 13F filings for Q2 2021.